Immunohistochemical (IHC) staining demonstrated upregulation of both MLKL and p-MLKL in samples of cerebral cortex from AD patients at Braak VI stage compared to age-matched healthy controls (Ctrl) (Figure 1A, Figure S1). Here, MLKL is linked to Alzheimer disease.